Teva Pharmaceutical Industries (TEVA) Dividends Paid - Common (2009 - 2018)

Teva Pharmaceutical Industries (TEVA) has reported Dividends Paid - Common for 10 consecutive years, with $12.0 million the latest figure, recorded in Q1 2018.

• For the quarter ending Q1 2018, Dividends Paid - Common fell 96.53% year-over-year to $12.0 million; the trailing twelve-month figure through Dec 2018 stood at $12.0 million (down 98.67% YoY), and the FY2018 full-year result was $12.0 million, down 98.67% from the prior year.
• Dividends Paid - Common eased to $12.0 million in Q1 2018 per TEVA's latest filing, from $87.0 million in the prior quarter.
• Across five years, Dividends Paid - Common topped out at $346.0 million in Q4 2016 and bottomed at $12.0 million in Q1 2018.
• Historically, Dividends Paid - Common has averaged $266.3 million across 5 years, with a median of $291.0 million in 2014.
• The sharpest annual moves came in 2016 and 2018: Dividends Paid - Common climbed 19.31% in 2016, then sank 96.53% in 2018.
• Over 5 years, Dividends Paid - Common stood at $272.0 million in 2014, then gained by 6.62% to $290.0 million in 2015, then climbed by 19.31% to $346.0 million in 2016, then plunged by 74.86% to $87.0 million in 2017, then sank by 86.21% to $12.0 million in 2018.
• According to Business Quant data, Dividends Paid - Common over the past three periods registered $12.0 million, $87.0 million, and $123.0 million for Q1 2018, Q4 2017, and Q3 2017 respectively.